293 related articles for article (PubMed ID: 11584766)
1. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
Tucker T; Yeats J
S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
[No Abstract] [Full Text] [Related]
2. Access to essential medications for HIV/AIDS in South Africa.
Andrews S
S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
[No Abstract] [Full Text] [Related]
3. Generic drugs battle moves from South Africa to Kenya.
Siringi S
Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
[No Abstract] [Full Text] [Related]
4. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11785481
[No Abstract] [Full Text] [Related]
5. Working together to provide generics for health.
Beck EJ; Reiss P
Antivir Ther; 2014; 19 Suppl 3():1. PubMed ID: 25310234
[No Abstract] [Full Text] [Related]
6. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
[No Abstract] [Full Text] [Related]
7. Cheap HIV drugs for developing countries.
Int J Epidemiol; 2001 Jun; 30(3):651-2. PubMed ID: 11460820
[No Abstract] [Full Text] [Related]
8. Is there a role for generic antiretroviral drugs in the United States?
Wormser GP; Lappas T
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):897-9. PubMed ID: 24918192
[TBL] [Abstract][Full Text] [Related]
9. World Trade Organization still threatens supply of affordable AIDS drugs.
Hagmann M
Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
[No Abstract] [Full Text] [Related]
10. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
11. Physicians say generic AIDS drugs don't threaten R&D.
AIDS Policy Law; 2002 Mar; 17(6):4. PubMed ID: 12004757
[No Abstract] [Full Text] [Related]
12. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
Kazatchkine M; Moatti JP
Med Sci (Paris); 2008 Dec; 24(12):1007-8. PubMed ID: 19116101
[No Abstract] [Full Text] [Related]
13. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
14. Access to HIV drugs: are we changing the two world paradigm?
Lazzarini Z
Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
[No Abstract] [Full Text] [Related]
15. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
Cohen J
Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
[No Abstract] [Full Text] [Related]
16. Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection.
Maher D; von Schoen-Angerer T; Cohn J
Int J Clin Pract; 2011 Aug; 65(8):824-7. PubMed ID: 21762306
[No Abstract] [Full Text] [Related]
17. The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report.
Herrmann S; Wardrop J; John M; Gaudieri S; Lucas M; Mallal S; Nolan D
Sex Health; 2012 Nov; 9(5):407-13. PubMed ID: 22950904
[TBL] [Abstract][Full Text] [Related]
18. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
[TBL] [Abstract][Full Text] [Related]
20. Production of antiretroviral drugs in middle- and low-income countries.
Pinheiro Edos S; BrĂ¼ning K; Macedo MF; Siani AC
Antivir Ther; 2014; 19 Suppl 3():49-55. PubMed ID: 25310755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]